Controlled Release from Solid Pharmaceutical Formulations of two Nalkanoyl- 4-methoxybicyclo[4.2.0]octa-1,3,5-trien-7-ethanamines with Melatoninergic Activity

Author(s): Marilena Vlachou, Vasiliki Ioannidou, Maria Vertzoni, Andrew Tsotinis, Pandelis A. Afroudakis, David Sugden

Journal Name: Letters in Drug Design & Discovery

Volume 12 , Issue 4 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The design, pharmacological properties and delivery characteristics in gastric and intestinal fluids of N-alkanoyl-4-methoxybicyclo[4.2.0]octa-1,3,5-trien-7-ethanamines, (I) and (II), are described. The biological activity of compounds (I) and (II) was determined in a specific model of melatonin action, the pigment aggregation response of Xenopus laevis melanophores. Both analogues were found to be powerful melatonin receptor agonists and showed satisfactory release characteristics, comparable to melatonin, from solid pharmaceutical formulations.

Keywords: Design, drug delivery, melatoninergic potency, N-alkanoyl-4-methoxybicyclo[4.2.0]octa-1, 3, 5-trien-7-ethanamines.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 04 February, 2015
Page: [259 - 262]
Pages: 4
DOI: 10.2174/1570180811666141024005226
Price: $65

Article Metrics

PDF: 29